Most Americans support it. Virtually all other developed countries already do it. And the two leading presidential candidates on both sides of the aisle agree: the federal government should lower drug prices.
Mar 18, 2016
0
3
Scientists have been telling Americans about the benefits of healthy eating for decades, and yet more Americans are obese than ever—more than a third of the country.
Mar 2, 2016
0
63
Thanks to rising annual deductibles and a push toward consumer-driven health care, people are increasingly encouraged to shop around for medical care. Many states or state hospital associations have price transparency initiatives, ...
Jan 12, 2016
0
2
A new "Big Data" project from researchers at Carnegie Mellon University, Yale University, the University of Pennsylvania and the London School of Economics demonstrates that the prices hospitals negotiate with private health ...
Dec 16, 2015
0
0
The price of new cancer drugs varies widely (from 28% to 388%) between high-income countries in Europe, Australia, and New Zealand, new research published in The Lancet Oncology has found.
Dec 4, 2015
1
52
Derma-Smoothe oil is a topical treatment for eczema that cost $46 in 2009. This year, its retail drugstore price hit $323.
Nov 26, 2015
1
33
Prices among 19 brand-name prescription dermatologic drugs increased rapidly between 2009 and 2015, with prices for topical antineoplastic drugs to prevent the spread of cancer cells increasing an average of 1,240 percent, ...
Nov 25, 2015
0
0
In the U.S. spending on drugs represents 10% of overall health care costs.(1) Together, hospital and physician expenditures account for 6 times the spending on drugs.(2) Despite a recent uptick in the rate of drug cost growth, ...
Nov 11, 2015
2
12
(HealthDay)—Most Americans now support aggressive regulation to keep health care costs in check—including price caps on drugs, medical devices, and payments to doctors and hospitals, a new HealthDay/Harris Poll has found.
Nov 6, 2015
0
15
A Senate committee tasked with protecting seniors is launching an investigation into prescription drug pricing, responding to public anxiety about companies hiking prices for once-inexpensive medicines.
Nov 4, 2015
0
5
